Overview

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome

Status:
Withdrawn
Trial end date:
2021-04-19
Target enrollment:
Participant gender:
Summary
COVID-19 is a respiratory disease due to a novel coronavirus (SARS-CoV-2) that causes substantial morbidity and mortality. To date, no treatment has been proved to be effective in COVID-19. Elderly patients and patients with comorbidities have the worse prognosis with a higher risk of hospitalization, ICU admission and death. The efficacy of an early outpatient treatment could be suggested but need to be confirmed. This confirmation is mandatory to improve prognosis of COVID-19 but also to avoid unsuspected deleterious effect of drugs already used in clinical practice but not based on evidence.
Phase:
Phase 3
Details
Lead Sponsor:
Groupe Hospitalier Paris Saint Joseph
Treatments:
Azithromycin
Hydroxychloroquine
Lopinavir
Ritonavir